Background Although many patients with chronic obstructive pulmonary disease (COPD) require a prolonged length of stay (PLOS) following coronary artery bypass grafting (CABG), the impact of PLOS on long-term survival has not been examined in this population. Objectives To determine the association between PLOS and long-term survival among COPD and non-COPD patients after CABG and to examine consequent policy and practice-based implications. Methods A retrospective cohort study of CABG patients was conducted between 2002 and 2011. Long-term survival was compared in patients with and without COPD and stratified by PLOS. Hazard ratios (HR) and 95% confidence intervals (CI) were computed using a Cox regression model. Conclusions COPD and PLOS are 2 of many factors that affect long-term mortality in postoperative CABG patients. Aggressive treatment strategies aimed at early weaning off of mechanical ventilation and prevention of reintubation among COPD patients must be considered carefully as a means to reduce length of stay after CABG. Our results also have important implications for the long-term management of these patients and strategies for containing costs over the life course of the patient.
C
The prevalence of COPD among coronary artery bypass grafting (CABG) patients varies from 11% to 25.8%. [3] [4] [5] Among CABG patients, COPD is a predictor of prolonged length of stay (PLOS), prolonged mechanical ventilation, and postoperative complications (eg, pneumonia). [6] [7] [8] [9] COPD also is an important predictor of long-term survival following CABG. [3] [4] [5] However, little is known about the synergistic effect of PLOS and COPD on survival. COPD is an important topic to investigate in this era of cost containment and comparative effectiveness research. Ventilator hours, intensive care unit days, long-term survival, and total costs are areas with opportunities for improvement in the postoperative care and long-term management of COPD patients with coronary artery disease.
PLOS after cardiac surgery has a negative influence on long-term survival. [10] [11] [12] [13] For example, a prolonged stay greater than 3 days in the critical care unit was negatively associated with survival 3 years after cardiac surgery, with postoperative respiratory failure a predictor of a prolonged stay. 11 However, no preoperative risk assessment for respiratory comorbidity was noted, and follow-up of patients for only 3 years limited the data captured on long-term survival. Although COPD patients are more likely to require PLOS following surgery, the impact of hospital PLOS on long-term survival has not been examined in these patients after cardiac surgery. The purposes of our study were to determine the association between PLOS and long-term survival among COPD and non-COPD patients after CABG and to examine consequent policy and practice-based implications.
Methods
The institutional review board at East Carolina University reviewed and approved this study. Details of the database have been previously described and are summarized in the following paragraphs. [14] [15] [16] [17] [18] [19] [20] [21] 
Study Design
This was a retrospective analysis of a prospectively maintained database of patients undergoing first-time, isolated CABG at the East Carolina Heart Institute between 2002 and 2011. Demographic data, comorbid conditions, coronary artery disease severity, and surgical data were collected at the time of surgery. Patients with and without COPD were compared and stratified by PLOS. Only black and white patients were included, so as to minimize the potential for residual confounding (~1% other races). Racial identity was self-reported. Emergent cases (n = 105) were considered a clinically different population with a unique postoperative course and were excluded from our analysis, resulting in the final sample to address the purpose of this study (N = 4801).
Definitions
COPD was classified preoperatively on the basis of severity by using the following Society of Thoracic Surgeons (STS) database criteria; "Mild: forced expiratory volume in 1 second (FEV 1 ) 60% to 75% of predicted, and/or on chronic inhaled or oral 
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A prolonged hospital stay negatively influences long-term survival.
www.ajcconline.org bronchodilator therapy; Moderate: FEV 1 50% to 59% of predicted, and/or on chronic steroid therapy aimed at lung disease; and Severe: FEV 1 < 50% predicted, and/or Room Air PO 2 < 60 or Room Air PCO 2 > 50." 22 Hospital length of stay (LOS) was measured as the time from CABG to hospital discharge. PLOS was defined as a hospital LOS greater than 14 days, as previously published. 9 Mortality included any postoperative cause of death. Coronary artery disease was defined as at least 50% stenosis and confirmed by angiography before surgery. Insurance type was collected as a single variable field (primary payor) until the end of 2007. Beginning in 2008, both primary and secondary payor information were collected as required variable fields in the STS database. Accordingly, we grouped patients who were uninsured with patients who had Medicaid and/or Medicare insurance.
Setting
Vidant Medical Center, which comprises 1500 beds, includes the heart institute, which is a tertiary referral, population-based cardiovascular facility (120 beds) serving a rural, predominantly low income, and racially dichotomous population. The East Carolina Heart Institute is the largest stand-alone hospital devoted to cardiovascular treatment in the state of North Carolina and supports state-of-the-art, multidisciplinary cardiovascular care. Cardiovascular disease is a main cause of death in North Carolina, with a disproportionately high number of cases occurring in the eastern region of the state. 23 More than 90% of patients admitted for CABG surgery at the heart institute live and remain within a 150-mile radius of the medical center.
Data Collection
The primary sources of data extraction were the STS Adult Cardiac Surgery Database and the electronic medical record (EMR).
Cardiovascular surgery information at our facility has been reported to the STS for more than 2 decades. Data quality and cross-field validation are regularly performed by the Center for Epidemiology and Outcomes Research at the institute. An EMR was introduced in 1997. Local and regional clinics in our system were consolidated under a single EMR in 2005, which allowed efficient follow-up of patients.
The National Death Index (NDI) was used to ascertain death dates for patients lost to follow-up and also was used to verify death information captured in our EMR. [24] [25] [26] A multiple-criteria deterministic matching algorithm, including social security number, was used to link data with the NDI. 26 The use of social security number as a patient identifier was proscribed within our university system at the end of 2011 in accordance with §205(r) of the Social Security Act. 27 Thus, patients in our study receiving surgery after 2012 were not included in the analysis. Less than 5% of confirmed deaths in our database failed to correctly match with the NDI.
Statistical Analysis
Categorical variables were reported as frequency and percentage, and continuous variables were reported as mean (standard deviation), median, and interquartile range. Variables not previously categorized were divided into quartiles before statistical analysis. Quartile categorization is beneficial because it limits the influence of outliers and allows assessment of trends across categories.
Follow-up was defined as the time from surgery to the date of death or censoring (loss to follow-up or end of follow-up). Survival probabilities were computed by using the Kaplan-Meier product-limit method and stratified by COPD and PLOS. An important advantage of this technique is that all patients do not need to be observed for the entire study period. 28 Moreover, rather than being grouped into intervals as is commonly done in actuarial life tables, the survival time for each patient is computed separately. 29 The log-rank test was used to compare survival between patients with and without COPD by PLOS. Cox proportional hazard regression models were used to compute mortality ratios (HRs) and 95% confidence intervals (CIs). Often used to estimate relative risk, HRs represent the relative instantaneous incidence of mortality between 2 groups. Cox regression is similar to traditional regression, with the exception that the dependent variable signifies the logarithm of the incidence rate 30 and accounts for various lengths of time for follow-up. In a Cox regression model, "independent variables are used to model the risk (or hazard) of experiencing an event at a given point in time, given that one has not experienced the event before that time." 28 Multivariable models included variables that have been previously reported to be associated with cardiovascular-related mortality, regardless of their statistical significance in our dataset. These included age, sex, race, hypertension, coronary artery disease severity, heart failure, and prior stroke. The post-hoc addition of other variables into the model was tested in a pairwise fashion. The method of Grambsch and Therneau 31 was used to confirm the proportional hazards assumption.
The National Death
Index was used to ascertain death dates for patients lost to follow-up.
The analysis was stratified by 2 equal time periods to assess temporality.
Statistical significance for categorical variables was tested by using the Fisher exact test for 2 2 comparisons and a 2 test for multiway comparisons. The Deuchler-Wilcoxon and Kruskal-Wallis methods were used to assess continuous variables. Trend for increasing/decreasing COPD severity by PLOS was assessed for statistical significance by using an exact Cochran-Armitage trend test. Similarly, the linear association for HRs across levels of PLOS-COPD was computed by using a likelihood ratio test, with the order of categories based on the a priori assumption of a greater force of mortality among patients with PLOS and COPD status. The analysis was stratified by 2 equal time periods to assess temporality during the study period. Missing values were present for ventilatory time (n = 6) and intensive care unit LOS (n = 372). An iterative expectation-maximization (EM) algorithm was used to account for missing values. [32] [33] [34] Covariables entered into the EM algorithm included hospital LOS, patient's age, sex, race, coronary artery disease severity, heart failure, and stroke. The imputation efficiency for the missing variables was greater than 98%. Statistical significance was defined as P less than .05. SAS Version 9.3 (SAS Institute Inc) was used for all analyses.
Results
A total of 203 patients (4.2%) had PLOS after CABG (N = 4801). COPD patients were more likely to have PLOS than were non-COPD patients (6.8% vs 3.6%; Fisher exact test, P < .001). After adjustment for age, sex, race, hypertension, coronary artery disease severity, heart failure, and prior stroke, a statistically significant linear trend for increasing COPD severity was observed among patients with PLOS (COPD: none, 4%; mild, 6%; moderate, 7%; severe, 15%) compared with patients without PLOS (COPD: none, 96%; mild, 94%; moderate, 93%; severe, 85%; Cochran-Armitage trend test, P < .001). Patients' characteristics and univariable survival, preoperative medications, and postoperative complications are shown in Tables 1, 2 , and 3. In our study population, the percentage of patients having "Medicaid," "Medicare," "Medicaid/Medicare," or "no insurance" as their primary payor status significantly differed by COPD status (COPD, 76%; non-COPD, 68%; Fisher exact test P < .001, not shown in tables). Furthermore, this payor group was significantly associated with worse long-term survival (adjusted HR = 1.9, 95% CI = 1.5-2.4) than patients who had private or military insurance. The median follow-up for study participants was 4.4 years.
Kaplan-Meier unadjusted survival curves are shown in the Figure. Five-year survival rates for non-COPD patients with and without PLOS were 54% and 88%, respectively. The 5-year survival rates for COPD patients with and without PLOS were 30% and 76%, respectively. Among patients without PLOS, the survival probability of patients with COPD versus those without COPD diverged. This trend was not observed for PLOS patients.
PLOS was observed to be a statistically significant predictor of decreased survival in COPD patients following CABG (Table 4) . The multivariable results did not substantively change with the pairwise addition of variables listed in Tables 1 and  2 , as well as left main coronary artery disease, recent smoker status, peripheral arterial disease, prior myocardial infarction, and prior percutaneous coronary intervention.
Discussion
Several studies [10] [11] [12] [13] have shown an inverse association between LOS in the intensive care unit after cardiac surgery and long-term survival. COPD is a predictor of PLOS and long-term survival following CABG. [3] [4] [5] To our knowledge, no studies have been published yet regarding the synergistic impact of PLOS on long-term survival among COPD patients after CABG.
Although postoperative complications were associated with PLOS for both COPD and non-COPD patients, COPD patients in our study were more likely than non-COPD patients to have postoperative development of pneumonia and acute respiratory distress syndrome, which required reintubation and prolonged ventilation. This reflects previous reports on this topic. [6] [7] [8] [9] Also similar to prior studies, 35, 36 payor status was associated with PLOS in our analysis. Because maintaining airway pressures of 10 cm H 2 O has been observed to significantly reduce atelectasis, pneumonia, and reintubation, 37, 38 prophylactic continuous positive airway pressure may benefit COPD patients following CABG. Furthermore, in patients already receiving mechanical ventilation, aggressive pulmonary physiotherapy and early tracheostomy have been observed to reduce duration of mechanical ventilation and hospital LOS. 39, 40 The influence of these practices on longterm survival among COPD patients after CABG warrants further investigation.
Patients with PLOS had noticeably higher short-term mortality than did patients without PLOS, regardless of COPD status. However, it appears that COPD may have a more sustained influence on long-term mortality than PLOS has, as illustrated by the continuing separation of the www.ajcconline.org "no PLOS" Kaplan-Meier survival curves shown in the Figure. Similarly divergent survival curves for COPD versus no COPD (not stratified by PLOS) were observed in the Northern New England Cardiovascular Disease Study analysis of 33 137 consecutive patients undergoing isolated CABG from 1992 through 2001. 4 Although we do not have a definitive explanation for this phenomenon, it conceivably may reflect a differential interaction with specific long-term sequelae, such as suboptimal follow-up care, inappropriate specialist referral, or inadequate health literacy of patients. The observation also may be attributed in part to underlying comorbid conditions such as diabetes, vascular disease, renal failure and renal insufficiency, peptic ulcer, cancer, and chronic heart failure. 4 In contrast, an early dominance effect of PLOS is noted by the parallel survival curves for COPD versus no COPD among patients with PLOS. Further examination of long-term factors associated with PLOS and COPD may assist in understanding this phenomenon.
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Medication
Table 2
Preoperative medications (N = 4801) PLOS 
PLOS No PLOS No PLOS
(77)
2932 (80) 2631 (71) 1344 (37) 847 (23) 2832 (77) 708 (19) 754 (20) 1601 (43) 125 (3) 443 (12) 25 (1) 917 (19) 718 (78) 655 (71) 361 (39) 209 (23) 680 (74) 177 (19) 244 (27) 439 (48) 54 (6) 118 (13) 14 ( 110 (81) 91 (67) 55 (40) 48 (35) 103 (76) 32 (24) 40 (29) 63 (46) 11 (8) 21 (15) 6 (4) 67 (1) 51 (76) 42 (63) 31 (46) 20 (30) 50 (75) 18 (27) 22 (33) 36 (54) 5 (7) 10 (15) 4 (6) 25 (1) 11 (<1) 23 (1) 55 (1) 41 (1) 12 (12) (2) 917 (19) 1 (<1) 11 (1) 10 (1) 11 (1) 17 (2) 20 (2) 14 ( 21 (15) 22 (16) 43 (32) 18 (13) 57 (42) 306 (640) (12) 67 (1) 1 (1) 16 (24) 16 (24) 27 (40) 21 (31) 35 (52) 431 (657) The mean baseline cost for CABG is $26 056 per surgery, but the cost associated with prolonged mechanical ventilation increases this mean cost by approximately $40 704. 42 Furthermore, the longterm cost per patient for a 12-year period has been estimated at $123 000, with an additional 2.3% increase attributable to comorbid conditions. 43 The preceding estimates highlight the importance of identifying patients who may be at highest risk for poor outcomes following CABG to guide future decision making and resource planning. This point is particularly salient in the context of cardiac rehabilitation, which has been associated with reduced postoperative morbidity and improved long-term survival in CABG patients. [44] [45] [46] [47] However, patients with COPD and other morbid conditions are significantly less likely to attend cardiac rehabilitation. 44, 45 Additionally, among patients eligible for Medicaid or Medicare, only 5.2% attend cardiac rehabilitation compared with 20.3% of noneligible patients. 45 The percentage of patients in our study without private insurance as their primary payor status differed significantly by COPD status. Furthermore, this payor group experienced significantly worse long-term survival than did patients having private or military insurance. Our findings are similar to results of a large 12-year, retrospective cohort study, which reported a 1.5-fold HR (95% CI = 1.1-2.1) for mortality associated with Medicaid insurance. 48 Conceivably, patients with both COPD and PLOS represented a population of patients at the extreme end of the severity spectrum that may be more susceptible to the impact of payor type.
The results of this study have important implications for the long-term management of patients with COPD undergoing CABG. Primary care providers may use this information to design interventions 
Multivariable HR (95%CI)
Abbreviations: CAD, coronary artery disease; CI, confidence interval; COPD, chronic obstructive pulmonary disease; HR, hazard ratio; PLOS, prolonged length of stay; Q1 quartile 1; Q2, quartile 2; Q3, quartile 3; Q4, quartile 4.
Medical management of COPD for patients with coronary artery disease should be considered.
aimed at decreasing postdischarge risk factors and to appropriately coordinate the ongoing care of their patients in a multimodal environment of clinical specialists and social workers. The information also may be useful when conversing with patients, aiding them to set realistic expectations of their outcomes and prompting lifestyle behavioral changes. One effective intervention that may explain the differential survival curves is participation in pulmonary rehabilitation that combines education and exercise training of patients. 49 Such rehabilitation remains a key factor in the postoperative management of COPD patients and improving health-related quality of life. 50 However, the careful monitoring and intervention of COPD symptoms, distress, and impaired functional status associated with fatigue, dyspnea, and depression also merit close attention on the part of health care providers. For example, the prevalence of fatigue among COPD patients has been estimated to be as high as 71%, 51 and fatigue is associated with an increase in the severity of pulmonary impairment 52 and COPD exacerbations. 53 Fatigue also is believed to adversely affect enrollment and participation, while increasing attrition in pulmonary rehabilitation programs. 54 Because COPD patients with fatigue benefit from enrollment in a 12-week rehabilitation program, 55 assessing for this symptom, especially in the context of PLOS, and encouraging participation in rehabilitation are warranted.
Health care providers also may play an important role in the immediate and long-term postoperative outcomes of CABG patients with COPD through the design and implementation of self-management interventions aimed at teaching patients the skills and behaviors necessary to optimally manage their disease. In a Cochrane review 56 of 23 studies on COPD patients participating in self-management, a statistically significant improvement in healthrelated quality of life was found when compared with patients undergoing usual care. Self-management also was associated with a decreased probability of hospitalization related to a respiratory problem.
Our findings raise important questions regarding the medical management of COPD and consequent long-term costs. Although CABG provides definitive symptomatic relief for COPD patients with coronary artery disease, medical management (eg, medication, lifestyle intervention, behavioral modification) may be acceptable in certain cases in lieu of surgery. Risk stratification models aimed at identifying patients at higher or lower risk of PLOS and the consequent impact on survival may facilitate the decision regarding the medical versus surgical management of COPD patients with coronary artery disease.
Strengths and Limitations
The current study is strengthened by its comparatively large sample size and long-term follow-up. Furthermore, we were able to determine time of death accurately by using a combination of the NDI and our comprehensive EMR.
Several limitations are inherent in our analysis. Survival after CABG among COPD patients varies by pulmonary disease severity. 5 Pulmonary function tests, such as measurement of FEV 1 values, were not repeated before surgery, and the effect of medical therapy may have resulted in some misclassification of COPD severity. However, COPD status was classified as a binary variable in our main analysis, and the misclassification of HRs by severity most likely would have biased results toward the null.
Previous studies have shown that administration of corticosteroids is associated with PLOS after adjusting for scores on the Acute Physiology and Chronic Health Evaluation II. 57 However, we adjusted for several other variables accounting for the patient's overall condition and need for supportive medications. Further inclusion of corticosteroids and similar medications in our model most likely would have resulted in overadjustment. Additionally, corticosteroids commonly are used to treat exacerbations and as maintenance therapy in COPD; therefore, we opted not to adjust for a variable that potentially is in the causal pathway. 58 Socioeconomic position, education, and income were not collected in our database and these factors may have influenced survival. 59 Additionally, we were unable to reliably estimate socioeconomic position by using zip codes because a large percentage of patients in our catchment area live in rural areas with postal box addresses.
Patients in this study were recruited for a relatively long period (10 years), and practice methods and clinical care may have changed during this time. However, results were consistent when the analysis was stratified by 2 time periods, indicating the robustness of the data to temporal changes. Furthermore, the status of some variables in our analysis may have changed during the study period. We did not adjust for these variables in a time-dependent fashion because of their potential to be in the casual pathway.
Cause of death is not recorded in the NDI, and COPD status may have been unrelated to patient mortality. Although we adjusted for known clinically relevant variables, other unmeasured factors could have influenced our results; retrospective www.ajcconline.org studies are susceptible to recall and selection biases. The association between COPD and poor survival could be noncausal in nature or related to noncardiac causes. 60 COPD was classified according to the STS criteria, and the findings of our study must be interpreted accordingly when making comparisons with other COPD staging systems such as the Global Initiative for Chronic Obstructive Lung Disease (GOLD) and the Body Mass Index, Airflow Obstruction, Dyspnea and Exercise Capacity (BODE) systems. [61] [62] [63] [64] The American Thoracic Society (ATS) and the European Respiratory Society (ERS) updated the Standards for the Diagnosis and Treatment of Patients with COPD in 2004 to provide guidance beyond the broad GOLD initiative. Both the GOLD and ATS/ERS guidelines are similar in classification and note the limitations of a staging system using FEV 1 in this complex patient population. Additionally, both guidelines note that the value of preoperative pulmonary function testing is undetermined in general surgery patients who have COPD. Finally, the STS classification system does not take into consideration extrapulmonary abnormalities such as obesity-related hypoventilation syndrome, pulmonary hypertension, and deconditioning. Consequently, these conditions were not accounted for in our analyses.
Conclusion
PLOS is a significant predictor of long-term survival in CABG patients, and our study demonstrates that this postoperative course is complicated by the presence of COPD. Following surgery, these patients may have a longer LOS than the general CABG population attributable to their pulmonary disease, which predisposes them to atelectasis, pneumonia, acute respiratory failure, and reintubation. Additional health service analysis is needed to determine if improved health insurance coverage, performance tracking, and outcome incentives will increase the long-term survival of COPD patients undergoing CABG. Future studies should evaluate the impact of treatment strategies and quality improvement measures as a means to decrease PLOS and improve long-term survival. Such evaluation is especially relevant to strategies and measures implemented during the acute phase and aimed at minimizing the incidence and duration of invasive mechanical ventilation.
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